Oral semaglutide and cardiovascular risk factors in high-risk type 2 diabetes: Post hoc analyses of a randomized clinical trial – SOUL

Mulvagh, Sharon L.; Inzucchi, Silvio E.; Marx, Nikolaus; Poulter, Neil R.; Deanfield, John E.; Pop-Busui, Rodica; Emerson, Scott S.; E., Johannes F.; M., Mads D.; Hovingh, G. Kees; Mandavya, Kabirdev; Davicevic-Elez, Zaklina; Jeppesen, Ole Kleist; Lorenzatti, Alberto; Oguz, Aytekin; Mankovsky, Boris; , Chaicharn Deerochanawong,; Gorgojo-Martinez, Juan J.; Ji, Linong; Bain, Steve; McGuire, Darren K.; Buse, John B.

doi:https://doi.org/

Journal article 225 views 3 downloads

Oral semaglutide and cardiovascular risk factors in high-risk type 2 diabetes: Post hoc analyses of a randomized clinical trial – SOUL

Sharon L. Mulvagh, Silvio E. Inzucchi, Nikolaus Marx, Neil R. Poulter, John E. Deanfield, Rodica Pop-Busui, Scott S. Emerson, Johannes F. E. Mann, Mads D. M. Engelmann, G. Kees Hovingh, Kabirdev Mandavya, Zaklina Davicevic-Elez, Ole Kleist Jeppesen, Alberto Lorenzatti, Aytekin Oguz, Boris Mankovsky, Chaicharn Deerochanawong, , Juan J. Gorgojo-Martinez, Linong Ji, Steve Bain

, Darren K. McGuire, John B. Buse

JAMA Cardiology

Swansea University Author: Steve Bain

PDF | Accepted Manuscript

Author accepted manuscript document released under the terms of a Creative Commons CC-BY licence using the Swansea University Research Publications Policy (rights retention).
Download (2.07MB)

Check full text

Published in:	JAMA Cardiology
ISSN:	2380-6583 2380-6591
Published:	American Medical Association
Online Access:	Check full text
URI:	https://cronfa.swan.ac.uk/Record/cronfa71266

College:	Faculty of Medicine, Health and Life Sciences

Oral semaglutide and cardiovascular risk factors in high-risk type 2 diabetes: Post hoc analyses of a randomized clinical trial – SOUL

Similar Items